Ah. Honkoop et al., PROGNOSTIC ROLE OF CLINICAL, PATHOLOGICAL AND BIOLOGICAL CHARACTERISTICS IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, British Journal of Cancer, 77(4), 1998, pp. 621-626
Forty-two patients with clinical stage IIIA or IIIB breast cancer were
treated with neoadjuvant chemotherapy followed by mastectomy and radi
otherapy, The median follow-up was 32 months (range 10-72 months) and
the median time to progression was 17 months (range 10-30 months). A m
ultivariate analysis showed that a longer disease-free survival (DFS)
was related to more chemotherapy cycles given (P = 0.003), a better pa
thological response to chemotherapy (P = 0.04) and fewer positive axil
lary lymph nodes (P = 0.05). A better overall survival (OS) was relate
d to more chemotherapy cycles given (P = 0.03) and better pathological
response to chemotherapy (P = 0.04). In patients with residual tumour
after neoadjuvant chemotherapy, high levels of staining for Ki-67 was
correlated with a worse DFS (P = 0.008). Other biological characteris
tics, including oestrogen receptor status, microvessel density (CD31 s
taining), P-glycoprotein (P-gp) staining and nuclear accumulation of p
53, were not independent prognostic factors for either DFS or OS. if b
oth P-gp and p53 were expressed, DFS and OS were worse in the uni-and
multivariate analysis. The preliminary results of this phase II study
suggest that coexpression of P-gp/p53 and a high level of staining for
Ki-67 after chemotherapy are associated with a worse prognosis, and t
hat prolonged neoadjuvant chemotherapy and the attainment of a patholo
gical complete remission are important factors in determining outcome
for patients with this disease.